Table 3 Evaluation of the efficacy of the treatment when the patient is not referred

ACUTE TREATMENT

(n = 134)

Total (n = 134) n (%)

France (n = 37) n (%)

Germany (n = 32) n (%)

Italy (n = 19) n (%)

Spain (n = 26) n (%)

UK (n = 20) n (%)

p value

NS

Patient perception

100 (74.6%)

30 (81.1%)

23 (71.9%)

14 (73.7%)

17 (65.4%)

16 (80.0%)

Patient diary

81 (60.4%)

21 (56.8%)

20 (62.5%)

12 (63.2%)

19 (73.1%)

9 (45.0%)

Validated scale

16 (11.9%)

3 (8.1%)

4 (12.5%)

2 (10.5%)

23 (23.1%)

1 (5.0%)

NS

Weekly

16 (11.9%)

6 (16.2%)

5 (15.6%)

2 (10.5%)

1 (3.9%)

2 (10.0%)

Monthly

67 (50.0%)

18 (48.7%)

12 (37.5%)

14 (73.7%)

13 (50.0%)

10 (50.0%)

Quarterly

36 (26.9%)

12 (32.4%)

10 (31.3%)

3 (15.8%)

8 (30.8%)

3 (15.0%)

Yearly

2 (1.5%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

2 (10.0%)

When patient comes and complains

13 (9.7%)

1 (2.7%)

5 (15.6%)

0 (0.0%)

4 (15.3%)

3 (15.0%)

PREVENTIVE TREATMENT (n = 118)

Total (n = 118) n (%)

France (n = 27) n (%)

Germany (n = 18) n (%)

Italy (n = 15) n (%)

Spain (n = 26) n (%)

UK (n = 32) n (%)

p value

NS

Patient perception

89 (75.4%)

21 (77.7%)

12 (66.6%)

10 (66.6%)

19 (73.1%)

27 (84.4%)

Patient diary

69 (58.5%)

17 (62.9%)

14 (77.7%)

10 (66.6%)

16 (61.5%)

12 (37.5%)

Validated scale

15 (13.7%)

2 (7.4%)

2 (11.1%)

2 (13.3%)

6 (23.1%)

3 (9.4%)

< 0.050

Weekly

7 (5.9%)

6 (22.2%)

1 (5.5%)

0 (0%)

0 (0%)

0 (0%)

Monthly

47 (39.8%)

9 (33.3%)

5 (27.8%)

8 (53.3%)

13 (50.0%)

12 (37.5%)

Quarterly

48 (40.7%)

12 (44.5%)

9 (50.0%)

7 (46.7%)

9 (34.6%)

11 (34.4%)

Yearly

4 (3.4%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

4 (12.5%)

When patient comes and complains

12 (10.2%)

0 (0%)

3 (16.7%)

0 (0%)

4 (15.4%)

5 (15.6%)